Recombinant Enterobacteria phage Sf6 Probable excisionase hkaC (18)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our default glycerol concentration is 50% and may serve as a reference.
Shelf Life
Shelf life depends on storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is determined during production. Specify your required tag type for preferential development.
Synonyms
18Probable excisionase hkaC
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-66
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Shigella phage Sf6 (Shigella flexneri bacteriophage VI) (Bacteriophage SfVI)
Target Names
18
Target Protein Sequence
MQHELQPDSL VDLKFIMADT GFGKTFIYDR IKSGDLPKAK VIHGRARWLY RDHCEFKNKL LSRANG
Uniprot No.

Target Background

Function

Excisionase and integrase are essential for site-specific recombination at the att site, enabling prophage excision from the host genome.

Database Links

KEGG: vg:2716661

Protein Families
Phage alpA excisionase family

Q&A

What is the primary function of excisionase hkaC in bacteriophage Sf6?

Excisionase hkaC in bacteriophage Sf6 functions primarily as a directionality factor that works in conjunction with integrase proteins to promote prophage excision from the bacterial genome during the switch from lysogenic to lytic growth. Unlike integrase proteins that catalyze both integration and excision reactions, excisionases specifically bias the reaction toward excision by binding to specific DNA sequences and altering the architecture of the recombination complex. The excisionase typically forms a nucleoprotein complex with the integrase at the attachment sites (attL and attR), remodeling these sites to favor excision over integration. This process is crucial for the phage life cycle, as it allows the phage genome to escape from the bacterial chromosome when conditions favor viral replication and host cell lysis.

What is the relationship between the Sf6 integrase and excisionase hkaC?

The relationship between Sf6 integrase and excisionase hkaC represents a carefully balanced regulatory system controlling phage genome integration and excision. While the integrase catalyzes the site-specific recombination between the phage attachment site (attP) and the bacterial attachment site (attB), resulting in integrated prophage flanked by attL and attR sites, the excisionase hkaC acts as a directional switch. During lysogeny, integrase expression predominates with minimal excisionase activity, maintaining the prophage state. When conditions trigger the lytic cycle, excisionase expression increases, forming a complex with integrase at the attL and attR sites. This complex reconfigures the DNA architecture to favor excision over integration, effectively reversing the integration reaction. The balance between these two proteins is crucial for determining the phage life cycle fate, with the integrase-only state favoring lysogeny and the integrase-excisionase complex promoting lytic growth.

What techniques are commonly used to detect excisionase activity in phage systems?

Several methodological approaches are employed to detect and characterize excisionase activity in phage systems:

  • In vitro recombination assays: Purified excisionase and integrase proteins are incubated with DNA substrates containing attL and attR sites. The excision products can be detected by gel electrophoresis, which separates the recombination products based on size.

  • In vivo excision monitoring: Genetic constructs with reporter genes flanked by attL and attR sites are introduced into bacterial cells expressing the excisionase and integrase. Excision events lead to reporter gene activation or inactivation, depending on the design.

  • Chromatin immunoprecipitation (ChIP): This technique identifies DNA-protein interactions by crosslinking proteins to DNA, followed by immunoprecipitation with antibodies specific to the excisionase and sequencing to identify binding sites.

  • Real-time PCR quantification: Primers designed to amplify across attL and attR sites, as well as the excised attP and attB products, can quantitatively measure excision rates.

  • DNA footprinting: This approach identifies the specific DNA sequences protected by excisionase binding, providing insights into the binding sites and potential mechanisms of action.

These methods collectively provide a comprehensive understanding of excisionase activity, binding specificity, and functional interactions with integrase and DNA substrates.

What strategies are most effective for expression and purification of recombinant Sf6 excisionase hkaC?

The effective expression and purification of recombinant Sf6 excisionase hkaC requires careful optimization of several parameters:

Expression System Selection:

  • E. coli BL21(DE3) is often the primary choice due to its reduced protease activity and compatibility with T7 promoter-based expression systems.

  • Alternative strains like Arctic Express or Rosetta may be beneficial if protein solubility or codon usage become limiting factors.

Vector Design Considerations:

  • Incorporate a C-terminal His6-tag rather than N-terminal tagging to minimize interference with DNA-binding domains, which are often located at the N-terminus of excisionases.

  • Include a TEV protease cleavage site to allow tag removal post-purification.

  • Consider fusion partners like MBP or SUMO that enhance solubility while retaining activity.

Optimized Expression Protocol:

  • Culture growth at 37°C until OD600 reaches 0.6-0.8

  • Temperature reduction to 18-25°C before induction

  • IPTG induction at lower concentrations (0.1-0.5 mM)

  • Extended expression period (16-20 hours) at reduced temperature

Purification Strategy:

  • Initial capture using nickel affinity chromatography with imidazole gradient elution

  • Tag removal using TEV protease (if included in design)

  • Ion exchange chromatography (typically cation exchange as excisionases are often positively charged)

  • Size exclusion chromatography for final polishing and buffer exchange

Buffer Optimization:

  • Include glycerol (10-15%) to enhance stability

  • Maintain reducing conditions with 1-5 mM DTT or 2-ME

  • Test various salt concentrations (150-500 mM NaCl) to balance solubility and DNA-binding activity

  • Consider adding DNA-binding stabilizers for long-term storage

This methodological approach typically yields protein of >95% purity suitable for both biochemical and structural studies.

How can one design experiments to study the binding specificity of Sf6 excisionase to its target DNA sequences?

Designing experiments to study Sf6 excisionase hkaC binding specificity requires a multi-technique approach:

Electrophoretic Mobility Shift Assays (EMSA):

  • Generate DNA fragments containing putative binding sites from attL and attR regions

  • Design a series of mutated sequences with systematic base substitutions

  • Incubate labeled DNA with increasing concentrations of purified excisionase

  • Analyze complex formation through native gel electrophoresis

  • Determine dissociation constants (Kd) and binding stoichiometry

DNase I Footprinting:

  • End-label DNA fragments containing predicted binding sites

  • Incubate with varying concentrations of excisionase

  • Perform limited DNase I digestion

  • Analyze protected regions by denaturing gel electrophoresis

  • Map the precise nucleotides involved in protein-DNA interactions

Systematic Evolution of Ligands by Exponential Enrichment (SELEX):

  • Generate a random oligonucleotide library

  • Incubate with immobilized excisionase protein

  • Wash away non-binding sequences

  • Elute and amplify bound sequences

  • Repeat selection cycles 4-6 times

  • Sequence enriched DNA pool to identify consensus binding motifs

Surface Plasmon Resonance (SPR):

  • Immobilize biotinylated DNA fragments on a streptavidin sensor chip

  • Flow excisionase protein solutions at various concentrations

  • Measure association and dissociation rates

  • Determine binding kinetics and thermodynamic parameters

X-ray or NMR Structural Studies:

  • Co-crystallize excisionase with DNA containing the binding site

  • Solve the structure to atomic resolution

  • Identify specific protein-DNA contacts

  • Validate interactions through mutagenesis of key residues

This comprehensive approach provides detailed information about binding sequence requirements, critical contact points, and the structural basis of excisionase-DNA recognition.

What role might excisionase hkaC play in host range determination of bacteriophage Sf6?

The excisionase hkaC may contribute to host range determination of bacteriophage Sf6 through several indirect mechanisms, although its primary function is in prophage excision rather than host recognition:

Integration Site Specificity:
The excisionase works in concert with integrase to determine site-specific recombination events. The efficiency of excision from different bacterial genomes may affect the ability of the phage to complete its life cycle in various hosts. Integration sites with different affinities for the integrase-excisionase complex could influence host range by affecting the probability of successful excision .

Regulatory Networks:
Excisionase expression is typically regulated by host and phage factors. The compatibility of these regulatory networks across different bacterial species or strains may determine whether appropriate excisionase expression occurs, thereby affecting the phage's ability to switch from lysogenic to lytic growth in particular hosts. Research has shown that bacteriophage Sf6 has recently expanded its host range to include S. flexneri serotype 2a 2 strains through mutations in its tailspike protein , but excisionase compatibility with host factors could represent an additional layer of host range determination.

Temporal Regulation:
The timing of excisionase expression during infection is critical for optimal phage reproduction. If this timing is disrupted in certain hosts due to incompatible regulatory elements, it could restrict host range by preventing efficient completion of the lytic cycle.

Recombination with Host Factors:
Excisionase may interact with host-encoded DNA-binding proteins that differ across bacterial species or strains. These interactions could influence excision efficiency and consequently affect host range.

Evolutionary Implications:
Changes in excisionase sequence or activity could potentially co-evolve with changes in host range determinants like the tailspike protein. The isolation of Sf6 host range mutants capable of infecting previously resistant serotypes suggests that multiple phage factors may evolve in concert to expand host range.

What are the structural characteristics of phage excisionases and how do they compare to other DNA-binding proteins?

Phage excisionases exhibit distinctive structural characteristics that enable their specialized function in prophage excision:

DNA-Binding Domain:

  • Usually contains a helix-turn-helix (HTH) or winged helix motif

  • The recognition helix fits into the major groove of DNA

  • Positively charged residues (Arg, Lys) create electrostatic interactions with the DNA backbone

  • Sequence-specific contacts often mediated by hydrogen bonding to nucleotide bases

Comparison with Other DNA-Binding Proteins:

FeaturePhage ExcisionasesBacterial Transcription FactorsIntegrasesRestriction Enzymes
SizeSmall (5-10 kDa)Variable (15-50 kDa)Larger (30-60 kDa)Medium to large (20-100 kDa)
DNA-binding motifPrimarily HTHHTH, zinc finger, etc.HTH + catalytic domainVariable recognition domains
OligomerizationOften monomeric or dimericCommonly dimericMonomeric to tetramericUsually dimeric
Binding specificityModerate to highHighHighVery high
Catalytic activityNone (architectural)None (regulatory)Yes (recombination)Yes (DNA cleavage)
Protein-protein interactionsStrong (with integrase)Variable (with RNA polymerase, etc.)Multiple (with excisionase, host factors)Limited

Structural Adaptations for Function:
Excisionases possess unique structural features adapted to their role as architectural proteins that remodel DNA-protein complexes. Unlike integrases, which must catalyze DNA strand exchange, excisionases function primarily by altering DNA conformation and modulating integrase activity. This is reflected in their smaller size and lack of catalytic domains. Their compact structure allows them to bind within complex nucleoprotein assemblies and induce conformational changes that favor excision over integration.

The structural simplicity of excisionases compared to integrases aligns with their specialized regulatory role in the directionality of site-specific recombination, highlighting nature's elegant solution to controlling bidirectional DNA rearrangements with minimal protein machinery.

How can CRISPR-Cas systems be used to study excisionase function in phage biology?

CRISPR-Cas systems offer powerful approaches for investigating excisionase function in phage biology:

Gene Knockout and Functional Analysis:

  • Design guide RNAs targeting the excisionase gene (hkaC) in the prophage

  • Introduce CRISPR-Cas9 system into lysogenic bacteria

  • Select cells with excisionase gene disruption

  • Assess prophage excision rates under inducing conditions

  • Measure phage production and lytic cycle progression

  • Complement with wild-type and mutant excisionase variants to verify phenotypes

CRISPRi for Conditional Regulation:

  • Utilize dCas9 (catalytically dead Cas9) fused to a transcriptional repressor

  • Target guide RNAs to the excisionase promoter region

  • Establish tunable repression by varying guide RNA expression

  • Create temporal control of excisionase expression

  • Monitor dose-dependent effects on prophage excision kinetics

  • Study the temporal requirements of excisionase during the phage life cycle

CRISPR-Based Imaging:

  • Fuse dCas9 to fluorescent proteins

  • Target guide RNAs to attL and attR sites

  • Visualize prophage excision events in real-time in living cells

  • Correlate excisionase expression with excision timing

  • Track the movement of phage DNA during the excision process

Base Editing Applications:

  • Use CRISPR base editors to introduce precise mutations in excisionase genes

  • Create libraries of excisionase variants with single amino acid substitutions

  • Screen for altered excision activity, DNA binding, or integrase interaction

  • Map structure-function relationships without complete gene disruption

  • Identify critical residues for excisionase function

Genomic Context Analysis:

  • Employ CRISPR-Cas9 to delete or rearrange sequences flanking integration sites

  • Assess how genomic context affects excisionase-mediated excision

  • Examine the influence of host factors by targeted disruption

  • Create synthetic integration sites to test sequence requirements

These CRISPR-based approaches provide unprecedented precision in manipulating and studying excisionase function in its native context, offering insights into the molecular mechanisms governing phage life cycle decisions.

What protocol should be followed to assess the kinetics of Sf6 excisionase-mediated prophage excision?

Protocol for Assessing Sf6 Excisionase-Mediated Prophage Excision Kinetics

Materials Required:

  • Lysogenic bacterial strain harboring Sf6 prophage

  • Induction agent (UV light, mitomycin C, or temperature shift)

  • Culture media (LB broth and agar plates)

  • DNA extraction kit

  • PCR reagents

  • Quantitative PCR system

  • Primers targeting various recombination junctions

  • Purified recombinant excisionase (for in vitro studies)

In Vivo Excision Kinetics Protocol:

  • Culture Preparation:

    • Grow lysogenic bacteria to mid-log phase (OD600 = 0.4-0.6)

    • Split culture into multiple aliquots for time-course sampling

  • Prophage Induction:

    • Add induction agent (e.g., mitomycin C at 0.5-1 μg/ml)

    • Maintain at appropriate growth temperature

  • Time-Course Sampling:

    • Collect samples at defined intervals (0, 15, 30, 45, 60, 90, 120 minutes post-induction)

    • Immediately process half of each sample for DNA extraction

    • Use remaining half to determine phage titer (PFU/ml)

  • DNA Junction Analysis:

    • Design primer pairs to detect:
      a) attL and attR (prophage-host junctions)
      b) attP (excised phage junction)
      c) attB (reconstituted bacterial attachment site)
      d) A control locus (for normalization)

    • Perform quantitative PCR on each sample

    • Calculate relative quantities of each junction type at each time point

  • Kinetic Parameter Determination:

    • Plot disappearance of attL/attR and appearance of attP/attB over time

    • Fit data to appropriate kinetic models

    • Calculate excision rate constants

  • Correlation Analysis:

    • Compare excision kinetics with:
      a) Free phage production
      b) Excisionase expression levels (via RT-qPCR)
      c) Cell lysis timing

In Vitro Excision Kinetics Protocol:

  • Substrate Preparation:

    • Clone attL and attR sites into plasmid vectors

    • Prepare supercoiled, nicked, and linear DNA substrates

  • Reaction Assembly:

    • Combine substrate DNA with purified integrase

    • Add varying concentrations of excisionase protein

    • Include necessary cofactors (IHF, buffer components)

  • Time-Course Sampling:

    • Remove aliquots at defined intervals (0, 5, 10, 20, 30, 60 minutes)

    • Stop reactions with EDTA/SDS

  • Product Analysis:

    • Separate recombination products by agarose gel electrophoresis

    • Quantify band intensities using densitometry

    • Calculate product formation rates

  • Kinetic Modeling:

    • Determine reaction order with respect to excisionase concentration

    • Calculate catalytic efficiency (kcat/KM)

    • Evaluate the effects of DNA topology on reaction rates

This comprehensive protocol enables detailed characterization of excisionase activity in both in vivo and in vitro contexts, providing insights into the mechanisms and regulation of prophage excision under various conditions.

How can one investigate the interaction between excisionase hkaC and integrase in the Sf6 phage system?

Investigating Excisionase-Integrase Interactions in the Sf6 Phage System

The functional relationship between excisionase hkaC and integrase can be thoroughly investigated using the following complementary approaches:

Biochemical Interaction Studies:

  • Co-immunoprecipitation (Co-IP):

    • Express epitope-tagged versions of both proteins in E. coli

    • Prepare bacterial lysates under various conditions

    • Perform pull-down with antibodies against one protein

    • Analyze co-precipitated proteins by western blotting

    • Test interactions in the presence/absence of attL/attR DNA

  • Surface Plasmon Resonance (SPR):

    • Immobilize purified integrase on a sensor chip

    • Flow excisionase at various concentrations

    • Measure binding kinetics (kon, koff, KD)

    • Determine how DNA substrates affect protein-protein interactions

    • Evaluate the effects of mutations on binding parameters

  • Isothermal Titration Calorimetry (ITC):

    • Titrate excisionase into integrase solution

    • Measure heat changes during binding

    • Determine thermodynamic parameters (ΔH, ΔS, ΔG)

    • Assess stoichiometry of the interaction

Structural Characterization:

  • X-ray Crystallography:

    • Co-crystallize excisionase-integrase complex

    • Solve structure at atomic resolution

    • Identify interface residues and binding motifs

    • Visualize conformational changes upon complex formation

  • Nuclear Magnetic Resonance (NMR):

    • Perform chemical shift perturbation analysis

    • Map interaction surfaces on both proteins

    • Study dynamics of the interaction in solution

    • Evaluate the effects of DNA binding on protein-protein interfaces

  • Cryo-Electron Microscopy:

    • Visualize larger nucleoprotein complexes

    • Reconstruct 3D structures of excisionase-integrase-DNA assemblies

    • Determine architectural changes in recombination complexes

Functional Studies:

  • Site-Directed Mutagenesis:

    • Mutate predicted interface residues in both proteins

    • Assess effects on protein-protein binding

    • Measure impact on excision activity

    • Create a structure-function map of the interaction

  • In Vitro Excision Assays:

    • Reconstitute excision reaction with purified components

    • Test how varying excisionase:integrase ratios affect reaction rates

    • Determine the order of assembly on DNA substrates

    • Identify rate-limiting steps in the reaction

  • Fluorescence Resonance Energy Transfer (FRET):

    • Label excisionase and integrase with fluorophore pairs

    • Monitor interaction in real-time

    • Measure conformational changes during complex assembly

    • Track protein dynamics during the excision reaction

In Vivo Approaches:

  • Bacterial Two-Hybrid Assays:

    • Fuse proteins to complementary fragments of a reporter

    • Quantify interaction strength in living cells

    • Screen for interaction-defective mutants

    • Test effects of physiological conditions on interaction

  • Microscopy-Based Methods:

    • Create fluorescent protein fusions of excisionase and integrase

    • Visualize co-localization in bacterial cells

    • Perform fluorescence recovery after photobleaching (FRAP)

    • Measure protein dynamics during prophage induction

This multi-faceted approach provides comprehensive characterization of the excisionase-integrase interaction, yielding insights into both molecular mechanisms and physiological regulation of the directionality switch controlling prophage excision.

What are the best techniques for monitoring phage Sf6 integration and excision in real-time?

Real-Time Monitoring of Phage Sf6 Integration and Excision

Tracking the dynamic processes of phage integration and excision in real-time requires sophisticated methodological approaches that combine molecular biology, imaging, and biophysical techniques:

Single-Cell Fluorescence Microscopy:

  • Fluorescent Reporter Systems:

    • Engineer a dual-color system where:

      • YFP expression occurs only in the integrated state (controlled by a promoter split across attB/attP)

      • mCherry expression occurs upon excision (promoter reconstituted across attL/attR)

    • Perform time-lapse microscopy during lysogeny establishment and prophage induction

    • Quantify fluorescence intensity changes in individual cells

    • Correlate with cell fate (lysis vs. continued growth)

  • DNA Locus Tracking:

    • Incorporate FROS (Fluorescent Repressor-Operator System) or ParB-parS near integration sites

    • Label phage and bacterial attachment regions with different fluorophores

    • Track the spatial dynamics of these loci during integration/excision events

    • Measure co-localization patterns and movement within the cell

Molecular Beacon Technology:

  • Integration/Excision-Specific Molecular Beacons:

    • Design molecular beacons that fluoresce only when hybridized to:

      • Newly formed attL/attR junctions (integration)

      • Reconstituted attP and attB sites (excision)

    • Introduce beacons into cells via electroporation

    • Monitor fluorescence changes using confocal microscopy or flow cytometry

    • Quantify kinetics at the population level

CRISPR-Based Visualization:

  • dCas9-Fluorescent Protein Fusions:

    • Target catalytically inactive Cas9 fused to fluorescent proteins to:

      • attB site in bacterial genome (one color)

      • Phage genome (different color)

    • Observe co-localization during integration

    • Monitor separation during excision

    • Achieve temporal resolution by synchronized induction

Genomic Methods:

  • Real-Time qPCR:

    • Design primers spanning all four junction types (attP, attB, attL, attR)

    • Extract DNA at short intervals after induction

    • Perform high-throughput qPCR to quantify junction changes

    • Calculate rate constants for integration and excision

  • Oxford Nanopore Sequencing:

    • Extract DNA at defined timepoints after induction

    • Perform long-read sequencing to capture integration/excision junctions

    • Analyze in real-time using the MinION platform

    • Identify integration site preferences and excision kinetics

Biophysical Approaches:

  • Surface Plasmon Resonance (SPR) with Cellular Extracts:

    • Immobilize DNA containing attP, attB, attL, or attR sites

    • Flow cell extracts from bacteria at various stages of infection

    • Monitor binding events in real-time

    • Detect formation of integration/excision complexes

  • Single-Molecule FRET:

    • Label attL/attR DNA with FRET pairs

    • Add purified integrase and excisionase

    • Monitor conformational changes during excision

    • Identify intermediate states and reaction paths

Practical Implementation Table:

TechniqueTemporal ResolutionSpatial ResolutionSingle-Cell CapabilityTechnical ComplexityKey Advantage
Fluorescent ReportersMinutesCellularYesModerateNon-invasive, long-term tracking
DNA Locus TrackingSecondsSub-cellularYesHighSpatial information
Molecular BeaconsMinutesLimitedYesModerateJunction-specific signals
CRISPR VisualizationMinutesSub-cellularYesHighSpecific DNA targeting
Real-Time qPCRMinutesNoneNoLowQuantitative, high-throughput
Nanopore SequencingHoursNoneNoModerateComprehensive junction analysis
SPR AnalysisSecondsNoneNoHighDetailed binding kinetics
Single-Molecule FRETMillisecondsMolecularNoVery highMechanistic insights

These complementary approaches provide a comprehensive toolkit for investigating the real-time dynamics of Sf6 phage integration and excision across multiple scales, from molecular interactions to whole-cell behaviors.

What are the critical parameters to optimize when studying excisionase-DNA interactions in vitro?

Critical Parameters for Optimizing Excisionase-DNA Interaction Studies In Vitro

Successful characterization of excisionase-DNA interactions requires careful optimization of multiple experimental parameters:

1. Protein Preparation:

  • Purity Considerations:

    • Achieve >95% purity using multi-step chromatography

    • Verify absence of nuclease contamination

    • Confirm proper folding via circular dichroism spectroscopy

    • Assess oligomeric state using size exclusion chromatography

    • Avoid freeze-thaw cycles that may compromise activity

  • Storage Conditions:

    • Determine optimal buffer composition (typically includes):

      • 20-50 mM Tris-HCl or HEPES (pH 7.5-8.0)

      • 100-200 mM NaCl or KCl

      • 1-5 mM DTT or β-mercaptoethanol

      • 10% glycerol

    • Aliquot and flash-freeze in liquid nitrogen

    • Store at -80°C for long-term stability

2. DNA Substrate Design:

  • Sequence Selection:

    • Include complete excisionase binding sites from attL/attR regions

    • Incorporate flanking sequences (≥10 bp on each side)

    • Design control substrates with mutated binding sites

    • Consider both minimal binding sites and full recombination substrates

  • DNA Preparation Methods:

    • Compare chemically synthesized versus PCR-amplified substrates

    • Assess the impact of different labeling strategies:

      • Fluorescent end-labeling (FAM, Cy3, Cy5)

      • Internal labeling with modified nucleotides

      • Biotin labeling for surface immobilization

    • Purify DNA using gel extraction or HPLC

3. Buffer Optimization:

  • Critical Components to Titrate:

    ComponentTypical RangeEffect on Interaction
    pH6.5-8.5Alters protein charge and DNA backbone interactions
    Monovalent ions (Na+, K+)50-300 mMShields electrostatic interactions
    Divalent ions (Mg2+, Ca2+)0-10 mMAffects DNA structure and protein folding
    Reducing agents0.1-5 mMMaintains protein redox state
    Detergents (Tween-20, NP-40)0.01-0.1%Reduces non-specific interactions
    Carrier proteins (BSA)0.01-0.1%Prevents surface adsorption
    Glycerol0-15%Stabilizes protein structure
  • Temperature Effects:

    • Perform binding assays at multiple temperatures (4°C, 25°C, 37°C)

    • Construct van't Hoff plots to determine thermodynamic parameters

    • Consider temperature-dependent structural changes in both protein and DNA

4. Assay-Specific Parameters:

  • Electrophoretic Mobility Shift Assay (EMSA):

    • Optimize gel percentage (6-8% for larger complexes)

    • Test various polyacrylamide:bisacrylamide ratios

    • Determine optimal running conditions (voltage, temperature)

    • Evaluate different visualization methods (autoradiography vs. fluorescence)

  • Fluorescence Anisotropy:

    • Determine optimal protein:DNA concentration ratios

    • Minimize photobleaching effects

    • Correct for inner filter effects at high protein concentrations

    • Control for buffer-dependent fluorophore behavior

  • Surface Plasmon Resonance:

    • Optimize ligand immobilization density

    • Determine appropriate flow rates for kinetic vs. equilibrium analysis

    • Control for mass transport limitations

    • Develop appropriate regeneration conditions

5. Data Analysis Considerations:

  • Binding Models:

    • Test multiple binding models:

      • Simple 1:1 binding

      • Cooperative binding

      • Multiple independent sites

      • Induced fit or conformational selection

    • Validate model selection statistically

  • Control Experiments:

    • Include non-specific DNA competition assays

    • Perform specificity controls with mutated binding sites

    • Assess buffer components for interference effects

    • Include inactive protein controls (heat-denatured)

By systematically optimizing these parameters, researchers can establish robust and reproducible assays for characterizing excisionase-DNA interactions, providing reliable insights into binding specificity, affinity, and the structural basis of recognition.

What are common challenges in recombinant expression of excisionase proteins and how can they be overcome?

Common Challenges in Recombinant Excisionase Expression and Solutions

Recombinant production of functional excisionase proteins presents several technical challenges that require systematic troubleshooting approaches:

Poor Expression Yields

ChallengePotential CausesSolutions
Low protein productionCodon biasUse codon-optimized synthetic genes or Rosetta strains with rare tRNAs
Toxicity to hostSwitch to tight expression control systems (pET with T7-lysozyme)
Promoter leakinessUse glucose to suppress basal expression in T7 systems
Inefficient translationOptimize ribosome binding site, consider using translation enhancers
Protein degradationProtease sensitivityInclude protease inhibitors, use protease-deficient strains (BL21)
Intrinsic instabilityCo-express with integrase or DNA binding partners

Solution Strategy: Start with a systematic expression screen using multiple constructs (different tags, positions), expression strains, and induction conditions. Monitor expression level and solubility in each condition by SDS-PAGE and western blotting.

Protein Solubility Issues

ChallengePotential CausesSolutions
Inclusion body formationImproper foldingLower induction temperature (16-20°C)
Reduce inducer concentration (0.1-0.3 mM IPTG)
Use auto-induction media for gradual expression
Hydrophobic regionsAdd solubility enhancers (0.1% Triton X-100, 1M sorbitol)
Co-express with chaperones (GroEL/ES, DnaK/J)
Lack of binding partnersCo-express with integrase or binding partners
Add stabilizing ligands (DNA fragments containing binding sites)

Solution Strategy: For proteins that remain insoluble despite optimization, consider refolding from inclusion bodies using gradual dialysis or on-column refolding techniques. Alternatively, employ solubility-enhancing fusion partners like MBP, SUMO, or Trx.

DNA Contamination

ChallengePotential CausesSolutions
Co-purification of nucleic acidsDNA-binding activityInclude high salt (0.5-1M NaCl) in lysis and wash buffers
Add nucleases (Benzonase, DNase I) during initial purification steps
Include polyethyleneimine (PEI) precipitation step (0.1-0.5%)
Charge-based interactionsPerform ion exchange chromatography under high salt conditions
Use heparin affinity chromatography as a pseudo-affinity step

Solution Strategy: Monitor DNA contamination using A260/A280 ratio throughout purification. Pure protein preparations should have A260/A280 ratios of ~0.57, while DNA contamination increases this value.

Protein Instability

ChallengePotential CausesSolutions
Aggregation during storageConcentration dependenceStore at moderate concentrations (0.5-1 mg/ml)
Oxidation of cysteinesInclude reducing agents (5 mM DTT or TCEP)
Temperature sensitivityStore at -80°C in small aliquots to avoid freeze-thaw cycles
Buffer incompatibilityScreen various buffer conditions using thermal shift assays
Activity loss over timeConformational changesAdd stabilizing ligands (DNA fragments, glycerol)
Proteolytic degradationInclude protease inhibitors in storage buffer
Add carrier proteins (BSA) at low concentrations

Solution Strategy: Perform stability tests under various storage conditions and monitor protein integrity by activity assays and SDS-PAGE over time.

Non-specific Interactions

ChallengePotential CausesSolutions
Co-purification of contaminantsNon-specific binding to matrixInclude low concentrations of detergents (0.05% Tween-20)
Optimize imidazole concentrations in wash buffers
Protein-protein interactionsAdd salt (200-500 mM NaCl) to disrupt ionic interactions
Include competitive agents (10-20 mM imidazole in lysis buffer)
Inefficient tag removalSteric hindranceExtend linker between protein and cleavage site
Optimize protease digestion conditions (time, temperature, buffer)

Solution Strategy: Implement multi-step purification procedures, combining different chromatographic techniques based on orthogonal properties (affinity, ion exchange, size exclusion).

By implementing these targeted solutions and systematically optimizing expression and purification conditions, researchers can overcome the common challenges associated with recombinant excisionase production, yielding functional protein suitable for downstream structural and biochemical studies.

How can researchers troubleshoot issues with phage integration and excision assays?

Troubleshooting Phage Integration and Excision Assays

Researchers frequently encounter technical challenges when studying phage integration and excision. Below is a comprehensive troubleshooting guide for addressing common issues:

PCR-Based Assay Failures

IssuePossible CausesDiagnostic ApproachSolutions
No amplification of junction fragmentsIncorrect primer designCheck primer locations relative to recombination sitesRedesign primers with 20-25 bp binding sites at appropriate distances from junctions
Sequence variationsCompare primer sequences with actual phage/host sequencesDesign degenerate primers or sequence-verify strains before assay design
Inhibitory components in samplesRun PCR with internal control templateOptimize DNA extraction protocol, include PCR enhancers (DMSO, betaine)
Non-specific amplificationPrimer cross-reactivityPerform in silico PCR against host/phage genomesIncrease annealing temperature, use touchdown PCR approaches
Secondary binding sitesAnalyze melt curves (for qPCR)Design new primers with higher specificity, use nested PCR
Inconsistent quantificationTemplate quality variationCheck DNA integrity on agarose gelsStandardize DNA extraction method, include internal control amplifications
PCR inhibitionInclude spike-in controlsDilute template or purify further

In Vivo Integration/Excision Efficiency Problems

IssuePossible CausesDiagnostic ApproachSolutions
Poor prophage inductionInsufficient inducerDose-response curve with inducerOptimize inducer concentration and exposure time
Resistant lysogenTest alternative induction methodsTry different induction methods (UV, temperature shift, chemical)
Defective prophageSequence key regulatory regionsUse control strains with known induction properties
Low integration efficiencySuboptimal attB siteCompare integration at different attB sitesTest alternative attachment sites or host strains
Inactive integraseExpress integrase from plasmidOptimize integrase expression levels
Host factors missingComplementation studiesSupply IHF, Fis or other host factors
Unstable lysogenySpontaneous inductionMonitor phage release in uninduced culturesOptimize growth conditions, use repressor-overexpressing strains
Growth disadvantageGrowth curve of lysogens vs. non-lysogensSelect for stable lysogens, use appropriate antibiotics

Biochemical Assay Challenges

IssuePossible CausesDiagnostic ApproachSolutions
No in vitro excisionInactive protein preparationsTest protein activity with control substratesOptimize protein purification, check for proper folding
Incorrect buffer conditionsSystematic buffer optimizationScreen various buffer compositions for optimal activity
Missing cofactorsAdd host factors (IHF, Fis)Supplement reactions with E. coli extracts or purified cofactors
Poor reaction kineticsSuboptimal protein:DNA ratioTitration experimentsDetermine optimal stoichiometry between components
Inhibitory contaminantsPurify components furtherUse size exclusion chromatography as final purification step
DNA topology constraintsCompare supercoiled vs. linear substratesUse appropriately supercoiled DNA substrates
Difficult product detectionLow reaction efficiencyIncrease reaction time or component concentrationOptimize detection method sensitivity
Complex product mixtureUse alternative product detection methodsConsider radioactive or fluorescent labeling for increased sensitivity

System-Specific Complications

IssuePossible CausesDiagnostic ApproachSolutions
Phage Sf6-specific problemsHost range limitationsTest various Shigella strainsConsider using Sf6 host range mutants like Sf6(2a)c
O-antigen interferenceLPS analysisUse LPS mutant strains or LPS-modifying enzymes
Competing integration sitesGenomic mapping of integration eventsPerform whole-genome sequencing to identify alternative sites
Host cell limitationsRestriction-modification barriersTest restriction-deficient hostsUse hosts lacking restriction systems or pre-modify phage DNA
Toxicity issuesMonitor cell viabilityUse regulated expression systems or less toxic protein variants
Competing prophagesProphage curingUse CRISPR-Cas to eliminate unwanted prophages

Analytical and Interpretive Challenges

IssuePossible CausesDiagnostic ApproachSolutions
Data inconsistencyTechnical variabilityReplicate analysisIncrease technical and biological replicates
Time-dependent effectsTime-course experimentsStandardize experimental timing
Mixed populationsSingle-cell analysisUse fluorescent reporters for single-cell resolution
Unexpected resultsAlternative recombination pathwaysMap actual recombination junctionsSequence recombination products
Cryptic attachment sitesGenome-wide integration mappingUse next-generation sequencing to identify all integration sites
Host factor variationComplementation studiesStandardize host background or supplement missing factors

By systematically implementing these troubleshooting approaches, researchers can overcome technical challenges in phage integration and excision assays, enabling reliable and reproducible characterization of these complex biological processes.

What are the most recent advancements in understanding phage excisionase function and applications?

Recent Advancements in Phage Excisionase Research and Applications

The field of phage excisionase research has seen significant progress in recent years, with advancements spanning basic science understanding to innovative biotechnological applications:

Structural Biology Breakthroughs:

High-resolution structures of excisionase-integrase-DNA complexes have revolutionized our understanding of the molecular basis of directional control in site-specific recombination. Recent cryo-electron microscopy studies have captured intermediate states during the excision reaction, revealing the dynamic assembly and disassembly of these nucleoprotein complexes. These structural insights have identified critical protein-protein and protein-DNA interfaces that determine the directionality of recombination, providing a mechanistic framework for understanding how small excisionase proteins can dramatically alter the outcome of recombination reactions.

Synthetic Biology Applications:

Engineered excisionase-integrase systems have emerged as powerful tools for precise genome manipulations. Recent developments include:

  • Memory Devices: Researchers have created genetic switches using excisionase-integrase pairs that respond to specific inputs and maintain their state through multiple cell divisions, effectively functioning as cellular memory devices for synthetic biology applications.

  • Logic Gates: Integration and excision events have been coupled to create Boolean logic operations within cells, allowing the construction of complex genetic circuits that process multiple inputs.

  • Targeted Integration: Modified excisionase-integrase systems have been engineered for site-specific integration of large DNA fragments into predefined genomic locations, offering advantages over traditional homologous recombination-based approaches.

Phage Therapy Relevance:

The isolation of new Sf6 host range mutants capable of infecting previously resistant Shigella flexneri serotypes has highlighted the importance of understanding phage life cycles for therapeutic applications. Excisionase function is crucial for efficient prophage induction and production of phage particles during phage therapy applications. Recent studies have focused on:

  • Controlled Lysis: Engineering excisionase expression systems to trigger controlled prophage induction in lysogenic phages, allowing for timed release of phage particles.

  • Expanded Host Range: Understanding how mutations in phage structural proteins like the tailspike of Sf6 allow infection of new hosts , while ensuring compatible excisionase function to maintain productive infection cycles.

  • Phage Cocktail Design: Development of diverse phage collections with complementary host ranges, including Sf6 variants that can target prevalent Shigella serotypes .

Systems Biology Insights:

Advanced sequencing and bioinformatic approaches have revealed unexpected complexity in excisionase-mediated processes:

  • Multiple Integration Sites: Studies have identified that some phages can integrate at multiple sites within a host genome, with excisionases showing varying efficiencies at different attachment sites . This has implications for host range determination and phage evolution.

  • Regulatory Networks: Global transcriptomic and proteomic analyses have mapped the complex regulatory networks controlling excisionase expression, revealing sophisticated control mechanisms that respond to environmental conditions and cellular stress.

  • Evolutionary Dynamics: Comparative genomic analyses across diverse phage families have traced the evolutionary history of excisionase-integrase pairs, revealing patterns of co-evolution and functional diversification.

Technological Innovations:

New methodologies have enhanced our ability to study excisionase function:

  • Single-Molecule Techniques: Real-time observation of individual excision events using fluorescence resonance energy transfer (FRET) has provided unprecedented insights into reaction mechanisms and kinetics.

  • High-Throughput Screening: Development of selection systems for identifying excisionase variants with altered specificity or enhanced activity has accelerated protein engineering efforts.

  • Computational Prediction: Advanced algorithms now allow more accurate prediction of excisionase binding sites and activity based on primary sequence information, facilitating the annotation of novel phage genomes.

These recent advances have expanded our fundamental understanding of excisionase biology while simultaneously opening new avenues for biotechnological applications in genome engineering, synthetic biology, and phage therapy.

How might excisionase research contribute to developing improved phage therapy approaches for Shigella infections?

Contributions of Excisionase Research to Advanced Phage Therapy for Shigella Infections

Excisionase research holds significant potential for enhancing phage therapy approaches against Shigella infections, particularly in addressing multidrug-resistant strains. The following areas represent key contributions of excisionase studies to improved therapeutic strategies:

Optimizing Phage Production and Formulation:

The efficiency of prophage excision directly impacts phage production yield, which is critical for therapeutic applications. Understanding excisionase function in the Sf6 phage system can lead to several practical improvements:

  • Enhanced Phage Production:

    • Engineered excisionase expression systems can increase phage production yields by optimizing the timing and efficiency of prophage induction

    • Controlled excision timing can minimize premature host cell lysis, maximizing phage burst size

    • Production of high-titer phage preparations is essential for effective therapy, especially for gastrointestinal applications where dilution effects are significant

  • Stability Improvements:

    • Understanding the molecular determinants of excisionase-integrase interactions can inform the development of stabilized phage variants

    • Modified excisionase systems can reduce spontaneous induction during storage, enhancing shelf-life of phage preparations

    • Engineering phages with regulated excisionase expression can improve stability in formulation buffers

Expanding Host Range Coverage:

Recent research has demonstrated the isolation of Sf6 host range mutants capable of infecting previously resistant Shigella flexneri serotypes, particularly the prevalent serotype 2a 2 . Excisionase research can further expand therapeutic coverage:

  • Compatible Excisionase Systems:

    • Ensuring that host range mutations in structural proteins (like tailspike) remain compatible with efficient excisionase function

    • Engineering excisionase variants that function optimally across diverse Shigella strains

    • Developing phage cocktails with complementary host ranges and efficient life cycles

  • Multi-Serotype Targeting:

    • The successful expansion of Sf6 host range to include serotype 2a 2 serves as a model for targeting other prevalent serotypes

    • Excisionase research can help ensure that engineered phages maintain efficient life cycles across different host backgrounds

    • Potential development of universal Shigella phages through combined structural and excisionase engineering

Overcoming Lysogeny-Based Resistance:

A major challenge in phage therapy is the development of resistance through lysogenization. Excisionase research offers strategies to address this limitation:

  • Prophage Induction Approaches:

    • Designing "Trojan horse" phages that efficiently establish lysogeny but carry inducible excisionase systems

    • Developing combination therapies where secondary agents trigger excisionase expression in lysogenized cells

    • Engineering cascade systems where initial phage infection triggers excisionase expression in pre-existing prophages

  • Exclusively Lytic Variants:

    • Engineering excisionase-deficient phages that cannot establish stable lysogeny

    • Creating phages with modified regulatory circuits that favor lytic growth

    • Developing phages with hyperactive excisionase variants that continually trigger excision, preventing stable lysogeny

Precision Targeting in Complex Environments:

The gastrointestinal environment presents significant challenges for phage therapy. Excisionase research can contribute to more precise targeting:

  • Environmentally-Responsive Systems:

    • Developing excisionase regulatory systems that respond to Shigella-specific environmental cues

    • Creating phages that specifically activate in the distal small intestine and colon where Shigella infections predominate

    • Engineering context-dependent excision systems that maximize activity in infection microenvironments

  • Reducing Off-Target Effects:

    • Minimizing prophage formation in beneficial microbiota through excisionase engineering

    • Designing host-specific regulatory circuits that prevent integration into non-target bacteria

    • Creating self-limiting phages that exhibit restricted replication cycles

Clinical Translation Advantages:

Excisionase research can address several practical challenges in clinical implementation of phage therapy:

  • Standardization and Quality Control:

    • Developing reporter systems based on excisionase activity for rapid quality assessment

    • Creating standardized excisionase assays to verify phage functionality

    • Establishing predictive markers for phage performance based on excision efficiency

  • Personalized Phage Therapy:

    • Rapidly assessing patient isolates for compatibility with available phage excisionase systems

    • Customizing phage cocktails based on excisionase functionality in patient-specific bacterial strains

    • Developing adaptive phage formulations that maintain efficacy across diverse clinical scenarios

Table: Comparison of Conventional vs. Excisionase-Enhanced Phage Therapy Approaches for Shigella

AspectConventional ApproachExcisionase-Enhanced ApproachClinical Advantage
Host RangeLimited to natural tropismExpanded through engineered Sf6 variants with optimized excisionase functionBroader coverage of clinical isolates
Resistance DevelopmentCommon through lysogenyReduced via excisionase control systemsImproved treatment durability
Production EfficiencyVariable and strain-dependentEnhanced via optimized excision systemsMore consistent manufacturing
Shelf LifeLimited by spontaneous inductionImproved via stabilized excisionase systemsBetter distribution logistics
Biofilm PenetrationOften poorEnhanced via controlled excision timingImproved efficacy against chronic infections
Dose StandardizationBased on PFU countsBased on functional excision assaysMore reliable clinical dosing
Combination TherapyAd hoc compatibilityRationally designed synergyEnhanced therapeutic outcomes

By integrating advanced knowledge of excisionase biology with innovative phage engineering approaches, researchers can develop next-generation phage therapeutics with enhanced efficacy against multidrug-resistant Shigella infections, addressing a critical global health challenge.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.